Showing results (281-290 of 409) with videos related to
Sort By:
Pageof 41
BMC Pulmonary Medicine|August 17, 2012
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort studyJorrit J Hofstra, Alexander P J Vlaar, David J Prins, et al.Kidney International Reports|June 25, 2021
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in AdultsThomas Barbour, Marie Scully, Gema Ariceta, et al.Blood Advances|July 10, 2026
Unbiased plasma proteomics reveals hemolysis during ADAMTS13 relapse in patients with immune TTPTim Postmus, Maryam Owais Subhan, Eva R Smit, et al.British Journal of Haematology|February 12, 2004
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteersNick R Bijsterveld, Roel Vink, Benien E van Aken, et al.Critical Care Medicine|May 9, 2012
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*Liesbeth M Kager, W Joost Wiersinga, Joris J T H Roelofs, et al.Thrombosis and Haemostasis|December 18, 2015
Supportive management strategies for disseminated intravascular coagulation. An international consensusAlessandro Squizzato, Beverley J Hunt, Gary T Kinasewitz, et al.American Journal of Respiratory Cell and Molecular Biology|April 19, 2008
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulationIda A J Giebelen, Masja Leendertse, Mark C Dessing, et al.Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.Critical Care Medicine|April 7, 2007
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in ratsGoda Choi, Jorrit-Jan H Hofstra, Joris J T H Roelofs, et al.Journal of Critical Care|June 6, 2007
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safetyPierre-Francois Laterre, David R Nelson, William Macias, et al.Pageof 41